Kyung Nam Pharm Co Ltd Total Liabilities

Latest as of June 2026: ₩25.73 Billion KRW ≈ $17.44 Million USD

Kyung Nam Pharm Co Ltd total liabilities. Based on the latest financial reports, Kyung Nam Pharm Co Ltd (053950) has total liabilities worth ₩25.73 Billion KRW (≈ $17.44 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Kyung Nam Pharm Co Ltd to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Kyung Nam Pharm Co Ltd (2007–2025)

Total liabilities of Kyung Nam Pharm Co Ltd from 2007 to 2025. This chart illustrates how Kyung Nam Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data.

Kyung Nam Pharm Co Ltd Competitors by Total Liabilities

The table below lists competitors of Kyung Nam Pharm Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Spacefy Inc F:YSP	Germany	€768.17K
Sabien Technology Group Plc LSE:SNT	UK	GBX927.00K
Catenai PLC LSE:CTAI	UK	GBX253.69K
Global UAV Technologies Ltd STU:YAB2	Germany	€1.49 Million
KRUNGTHAI CARD FGN BA 1 F:KRTA	Germany	€66.51 Billion
Gaucho Group Holdings, Inc. NASDAQ:VINOQ	USA	$10.85 Million
Next.e.GO N.V. NASDAQ:EGOXF	USA	$190.03 Million
PHSC PLC LSE:PHSC	UK	GBX772.62K

Liability Composition Analysis (2007–2025)

This chart breaks down Kyung Nam Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Kyung Nam Pharm Co Ltd balance sheet assets.

Liquidity & Leverage Metrics

Kyung Nam Pharm Co Ltd Total Liabilities Ratios Explained

Kyung Nam Pharm Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.25	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kyung Nam Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kyung Nam Pharm Co Ltd (2007–2025)

The table below shows the annual total liabilities of Kyung Nam Pharm Co Ltd from 2007 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩47.33 Billion ≈ $32.08 Million	-7.85%
2024-12-31	₩51.36 Billion ≈ $34.81 Million	-33.10%
2023-12-31	₩76.78 Billion ≈ $52.03 Million	+72.54%
2022-12-31	₩44.50 Billion ≈ $30.16 Million	-35.78%
2020-12-31	₩69.29 Billion ≈ $46.96 Million	+422.30%
2019-12-31	₩13.27 Billion ≈ $8.99 Million	-45.28%
2018-12-31	₩24.24 Billion ≈ $16.43 Million	-14.49%
2016-12-31	₩28.35 Billion ≈ $19.22 Million	-57.82%
2010-12-31	₩67.22 Billion ≈ $45.56 Million	+7.72%
2009-12-31	₩62.41 Billion ≈ $42.29 Million	+43.46%
2008-12-31	₩43.50 Billion ≈ $29.48 Million	+37.89%
2007-12-31	₩31.55 Billion ≈ $21.38 Million	--

About Kyung Nam Pharm Co Ltd

KQ:053950 Korea

Market Cap

$10.04K

₩14.82 Million KRW

Market Cap Rank

#31872 Global

#2122 in Korea

Share Price

₩1588.00

Change (1 day)

-4.28%

52-Week Range

₩1435.00 - ₩2295.00

All Time High

₩2295.00